Nudrug Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.31 Cr
- Revenue Growth 27.88%
- Profit Growth 15.74%
- Ebitda 38.19%
- Net Worth 29.02%
- Total Assets 26.69%
About Nudrug Pharmaceutical
Nudrug Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2016 (Eight years and nine months 5 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.31 Cr.
Amit Kadam, Ananda Hundalekar, and Deepaksingh Thakur serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24305PN2016PTC164481
-
Company No.
164481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Nudrug Pharmaceutical Private Limited offer?
Nudrug Pharmaceutical Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Nudrug Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kadam
|
Director | 13-May-2016 | Current |
|
Ananda Hundalekar
|
Director | 13-May-2016 | Current |
|
Deepaksingh Thakur
|
Director | 13-May-2016 | Current |
Financial Performance of Nudrug Pharmaceutical.
Nudrug Pharmaceutical Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 27.88% increase. The company also saw a substantial improvement in profitability, with a 15.74% increase in profit. The company's net worth Soared by an impressive increase of 29.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nudrug Pharmaceutical?
Unlock access to Nudrug Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹13.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
- Axis Bank Limited : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2024 | Others | ₹1.00 Cr | Open |
| 06 Sep 2023 | Axis Bank Limited | ₹3.10 M | Open |
How Many Employees Work at Nudrug Pharmaceutical?
Unlock and access historical data on people associated with Nudrug Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nudrug Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nudrug Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
